Cavanaugh C, Perazella MA (2019) Urine sediment examination in the diagnosis and management of kidney disease: core curriculum 2019. Am J Kidney Dis 73(2):258–272
Saha MK, Massicotte-Azarniouch D, Reynolds ML, Mottl AK, Falk RJ, Jennette JC, Derebail VK (2022) Glomerular hematuria and the utility of urine microscopy: a review. Am J Kidney Dis 80(3):383–392
Article CAS PubMed Google Scholar
Tsai JJ, Yeun JY, Kumar VA, Don BR (2005) Comparison and interpretation of urinalysis performed by a nephrologist versus a hospital-based clinical laboratory. Am J Kidney Dis 46(5):820–829
Yuan M, Tan Y, Li J, Yu X, Zhang H, Zhao M (2021) Urinary sediments could differentiate endocapillary proliferative lupus nephritis and endocapillary proliferative IgA nephropathy. Int Immunopharmacol 90:107122
Article CAS PubMed Google Scholar
Perazella MA, Coca SG, Hall IE, Iyanam U, Koraishy M, Parikh CR (2010) Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 5(3):402–408
Article PubMed PubMed Central Google Scholar
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, A. on behalf of the American Diabetes (2023) 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2023. Diabetes Care 46(Suppl 1):S191-s202
Article CAS PubMed Google Scholar
Okada S, Samejima KI, Matsui M, Morimoto K, Furuyama R, Tanabe K, Eriguchi M, Akai Y, Saito Y, Tsuruya K (2020) Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy. BMJ Open Diabetes Res Care 8(2):e001863
Article PubMed PubMed Central Google Scholar
Wu Y, Zhang J, Wang Y, Wang T, Han Q, Guo R, Zhang R, Ren H, Zhu Y, Xu H, Li L, Tong N, Liu F (2020) The association of hematuria on kidney clinicopathologic features and renal outcome in patients with diabetic nephropathy: a biopsy-based study. J Endocrinol Invest 43(9):1213–1220
Article CAS PubMed Google Scholar
Morcos M, Sayed AA, Bierhaus A, Yard B, Waldherr R, Merz W, Kloeting I, Schleicher E, Mentz S, Abd el Baki RF, Tritschler H, Kasper M, Schwenger V, Hamann A, Dugi KA, Schmidt AM, Stern D, Ziegler R, Haering HU, Andrassy M, van der Woude F, Nawroth PP (2002) Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 51(12):3532–3544
Article CAS PubMed Google Scholar
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612
Article PubMed PubMed Central Google Scholar
Lameire NH, Levin A, Kellum JA, Cheung M, Jadoul M, Winkelmayer WC, Stevens PE (2021) Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int 100(3):516–526
Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E, Joh K, Noel LH, Radhakrishnan J, Seshan SV, Bajema IM, Bruijn JA, S. Renal Pathology (2010) Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21(4):556–563
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, A. on behalf of the American Diabetes (2023) 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care 46(Suppl 1):S19-s40
Article CAS PubMed Google Scholar
Perazella MA, Coca SG (2012) Traditional urinary biomarkers in the assessment of hospital-acquired AKI. Clin J Am Soc Nephrol 7(1):167–174
Perazella MA (2015) The urine sediment as a biomarker of kidney disease. Am J Kidney Dis 66(5):748–755
Article CAS PubMed Google Scholar
Li MR, Sun ZJ, Chang DY, Yu XJ, Wang SX, Chen M, Zhao MH (2022) C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus. J Diabetes 14(4):291–297
Article CAS PubMed PubMed Central Google Scholar
Wang X, Ren L, Huang Y, Feng Z, Zhang G, Dai H (2023) The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease. Clin Chim Acta 547:117448
Article CAS PubMed Google Scholar
Oh SW, Kim S, Na KY, Chae DW, Kim S, Jin DC, Chin HJ (2012) Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res Clin Pract 97(3):418–424
Shimizu M, Furuichi K, Toyama T, Kitajima S, Hara A, Kitagawa K, Iwata Y, Sakai N, Takamura T, Yoshimura M, Yokoyama H, Kaneko S, Wada T (2013) Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy. Diabetes Care 36(11):3655–3662
Article CAS PubMed PubMed Central Google Scholar
Zhang J, Zhang J, Zhang R, Wang Y, Liang Y, Yang Z, Wang T, Xu X, Liu F (2020) Implications of immunoglobulin G deposit in glomeruli in Chinese patients with diabetic nephropathy. J Diabetes 12(7):521–531
Article CAS PubMed Google Scholar
Yildirim M, Bingol H, Cengil E, Aslan S, Baykara M (2023) Automatic classification of particles in the urine sediment test with the developed artificial intelligence-based hybrid model. Diagnostics (Basel) 13(7):1299
留言 (0)